# Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia

> **NCT06491004** · — · COMPLETED · sponsor: **Diasorin Italia S.p.A.** · enrollment: 281 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** PTX3 assay

## Key facts

- **NCT ID:** NCT06491004
- **Lead sponsor:** Diasorin Italia S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-20
- **Primary completion:** 2024-03-29
- **Final completion:** 2024-03-29
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06491004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06491004, "Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06491004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*